CN114652763A - Plant fermentation allergy-relieving composition and preparation method and application thereof - Google Patents
Plant fermentation allergy-relieving composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN114652763A CN114652763A CN202011539786.6A CN202011539786A CN114652763A CN 114652763 A CN114652763 A CN 114652763A CN 202011539786 A CN202011539786 A CN 202011539786A CN 114652763 A CN114652763 A CN 114652763A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- fermentation
- allergy
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 117
- 238000000855 fermentation Methods 0.000 title claims abstract description 92
- 230000004151 fermentation Effects 0.000 title claims abstract description 92
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 42
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000758 substrate Substances 0.000 claims abstract description 24
- 150000007524 organic acids Chemical class 0.000 claims abstract description 21
- 150000004676 glycans Chemical class 0.000 claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 claims abstract description 20
- 230000001954 sterilising effect Effects 0.000 claims abstract description 20
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 19
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 19
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 18
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 18
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 18
- 238000001914 filtration Methods 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 14
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 14
- 238000001816 cooling Methods 0.000 claims abstract description 14
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 13
- 244000146462 Centella asiatica Species 0.000 claims abstract description 13
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 13
- 241000894006 Bacteria Species 0.000 claims abstract description 12
- 241000219357 Cactaceae Species 0.000 claims abstract description 12
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 6
- 240000003538 Chamaemelum nobile Species 0.000 claims description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 6
- 240000002853 Nelumbo nucifera Species 0.000 claims description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 5
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 4
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 3
- 244000298697 Actinidia deliciosa Species 0.000 claims description 3
- 241001116389 Aloe Species 0.000 claims description 3
- 241001474374 Blennius Species 0.000 claims description 3
- 235000003880 Calendula Nutrition 0.000 claims description 3
- 240000001432 Calendula officinalis Species 0.000 claims description 3
- 244000077995 Coix lacryma jobi Species 0.000 claims description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims description 3
- 241000208680 Hamamelis mollis Species 0.000 claims description 3
- 244000178870 Lavandula angustifolia Species 0.000 claims description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- 244000197580 Poria cocos Species 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 235000011399 aloe vera Nutrition 0.000 claims description 3
- 235000006533 astragalus Nutrition 0.000 claims description 3
- 235000021014 blueberries Nutrition 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 239000001102 lavandula vera Substances 0.000 claims description 3
- 235000018219 lavender Nutrition 0.000 claims description 3
- 229940118846 witch hazel Drugs 0.000 claims description 3
- 229940087559 grape seed Drugs 0.000 claims description 2
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 claims 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 1
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- 241001061264 Astragalus Species 0.000 claims 1
- PGLIUCLTXOYQMV-UHFFFAOYSA-N Cetirizine hydrochloride Chemical compound Cl.Cl.C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PGLIUCLTXOYQMV-UHFFFAOYSA-N 0.000 claims 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims 1
- 240000008397 Ganoderma lucidum Species 0.000 claims 1
- 240000004371 Panax ginseng Species 0.000 claims 1
- 240000002547 Rosa roxburghii Species 0.000 claims 1
- 235000000640 Rosa roxburghii Nutrition 0.000 claims 1
- 210000004233 talus Anatomy 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 abstract description 9
- 230000007815 allergy Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 5
- 210000004927 skin cell Anatomy 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 244000042664 Matricaria chamomilla Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 33
- 239000000047 product Substances 0.000 description 31
- 241000411851 herbal medicine Species 0.000 description 29
- 238000001514 detection method Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 13
- 241000736199 Paeonia Species 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 238000011049 filling Methods 0.000 description 11
- 239000002994 raw material Substances 0.000 description 7
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 230000003266 anti-allergic effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 229940118019 malondialdehyde Drugs 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 238000008157 ELISA kit Methods 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 241001506047 Tremella Species 0.000 description 3
- 244000047670 Viola x wittrockiana Species 0.000 description 3
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241001523681 Dendrobium Species 0.000 description 2
- 229940090898 Desensitizer Drugs 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 229930195210 Ophiopogon Natural products 0.000 description 2
- 244000248557 Ophiopogon japonicus Species 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 235000011044 succinic acid Nutrition 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- 235000001405 Artemisia annua Nutrition 0.000 description 1
- 240000000011 Artemisia annua Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a plant fermentation allergy-relieving composition, a preparation method and application thereof, wherein the composition comprises 0.05-2 parts by weight of polyphenol, 0.5-5 parts by weight of crude polysaccharide and 0.1-3 parts by weight of organic acid. Preferably, the allergy-soothing composition is obtained by fermenting yeast in a plant fermentation substrate, wherein the fermentation substrate comprises chamomile, centella asiatica, peony, pseudo-ginseng, purslane, cactus and scutellaria baicalensis. The preparation method of the composition comprises the following steps: mixing the components in the fermentation substrate, adding water, heating to the temperature of 100-120 ℃, sterilizing, cooling to the temperature of 20-35 ℃, inoculating fermentation strains for fermentation, and filtering and sterilizing to obtain the plant fermentation allergy-relieving composition. The plant fermentation allergy-relieving composition can relieve skin allergy, resist bacteria and diminish inflammation, promote skin cell renewal and achieve the effects of resisting allergy and relieving allergy.
Description
Technical Field
The invention relates to the technical field of skin care, mainly relates to the technical field of skin care product production, and particularly relates to a plant fermentation allergy-relieving composition as well as a preparation method and application thereof.
Background
Skin allergy is a common skin disease, allergic people have sensitive skin, and adverse reactions can also occur when the cosmetic is applied to the skin easily. Common lipsticks, hair dyes and the like exist, and after the use, the problems of skin allergy such as red, swelling, heat, itching, pain, blister and the like appear. The inhibition and resistance of skin allergy are very important problems from the skin physiological and medical and cosmetic perspectives. Although the traditional control method treatment such as hormone treatment, antihistamine treatment and anti-inflammatory drug treatment can relieve and treat the skin allergy problem and symptoms within a certain time, if the traditional control method treatment is not used properly, the skin disease is likely to be aggravated, and even irreparable lesions of the skin can be caused. Therefore, the method is quite worthy of being researched for how to safely and effectively inhibit the skin allergy. How to reduce the allergic rate of cosmetics is a problem which needs to be solved urgently at present, and some enterprises add prohibited substances such as glucocorticoid to solve the problem, for example, in a unqualified cosmetic list published by the Guangdong food and drug administration 2015 at the 3 rd stage, 15 companies find out that the glucocorticoid is illegally added, and the long-term use of products containing glucocorticoid can cause serious consequences such as skin dependence and even ulceration. Therefore, the research of the plant-derived soothing agents is an important research direction at present and has practical significance for the cosmetic industry.
Research shows that substances with effective anti-aging and anti-allergic effects exist in a plurality of natural plant extracts, and the substances can be used for preparing cosmetics, skin care products or medicaments with anti-aging or anti-allergic effects. Natural plants or extracts thereof include: chamomile, witch hazel, scutellaria baicalensis, folium artemisiae argyi, grape seeds, blueberry, ginkgo, hawthorn, liquorice extract, glycyrrhizic acid, aloe, chamomile blue, peony, astragalus mongholicus, honeysuckle, indigowoad root bloom, centella asiatica, peony, kiwi fruit, roxburgh rose, calendula, lotus seeds, saussurea involucrate, ginseng, lavender, seaweed, honeysuckle, coix seed, lucid ganoderma, green tea, poria cocos and the like.
There are many studies of interest, CN200810033341.3 discloses an anti-aging and anti-allergy composition comprising: anti-aging and anti-allergy active ingredients prepared by mixing natural alpha-bisabolol of plant extracts and procyanidine, and a carrier acceptable for cosmetics, skin care products or medicines. The composition can produce anti-aging and anti-allergic effects far superior to those of natural alpha-bisabolol or proanthocyanidin used alone when applied to the skin. CN201510684956.2 discloses a plant desensitizer and a preparation method thereof, the preparation method comprises: weighing raw materials in proportion, and adding the raw materials into an extraction device for extraction to obtain an extracting solution A; filtering the extract A, and taking the permeated liquid as an extract B; concentrating the extract B to obtain the final product, namely the plant soothing and sensitizing agent; the raw materials comprise the following components in parts by weight: 20-30 parts of liquorice, 20-30 parts of sweet wormwood, 10-20 parts of gentian, 10-20 parts of radix sophorae flavescentis and 10-20 parts of fructus cnidii. The plant soothing agent for cosmetics is prepared by adopting a specific process, and is effective, stable and light in color. The prepared plant allergy relieving agent comprises 0.25-0.35% of glycyrrhizic acid and 0.61-0.87 mg/ml of artemisinin in percentage by mass. CN201310374302.0 discloses a plant composition with the effects of moisturizing, removing wrinkles and soothing allergy and a preparation method thereof. The active ingredients of the traditional Chinese medicine composition are water extracts of the following raw materials: herba Dendrobii, pansy, radix Ophiopogonis, Tremella and herba Avenae Fatuae; wherein the oat raw material is oat grains, oat flour or oat bran. In the composition, the mass ratio of the dendrobium to the pansy to the ophiopogon root to the tremella to the oat is 5-15: 2-10: 2-10: 1-5: 1-5, in particular 12: 6: 3: 2: 2. the invention selects the five plants of dendrobium, pansy, ophiopogon root, oat raw material and tremella to be combined and extracted for external use, and achieves the effects of moisturizing, delaying skin aging, resisting sensitivity and preventing chapping through the ways of retaining water, maintaining the physiological function of normal aquaporin and the like.
Disclosure of Invention
The technical problem solved by the invention is as follows: the safety and the efficacy of the existing allergy relieving agent are still to be improved, and the application of the plant fermentation composition to the skin relieving and anti-allergy effects is not seen at present.
The purpose of the invention is: the plant fermentation soothing agent is prepared by performing proper structural modification on active ingredients in natural plants through the biotransformation of microorganisms in a biological fermentation process to improve the efficacy of products and reduce the irritation to skin, and the active ingredients are synergistic with metabolites of the microorganisms, such as polypeptides, organic acids and amino acids, to improve the efficacy of the products.
In order to solve the technical problems, the invention provides a plant fermentation sensitizer, and a fermentation substrate comprises 0.1-30% of chamomile, 0.1-10% of centella asiatica, 0.1-20% of peony, 0.1-5% of pseudo-ginseng, 0.1-30% of purslane, 0.1-30% of cactus and 0.1-5% of scutellaria baicalensis. The prepared composition product has obvious allergy-relieving efficacy through efficacy tests.
Specifically, aiming at the defects of the prior art, the invention provides the following technical scheme:
the plant fermentation allergy-relieving composition is characterized by comprising the following components:
0.05-2 parts of polyphenol, 0.5-5 parts of crude polysaccharide and 0.1-3 parts of organic acid.
Preferably, the plant fermentation desensitizing composition comprises the following components: 0.05-2 wt% of polysaccharide, 0.5-5 wt% of crude polysaccharide, 0.1-3 wt% of organic acid and 85-98 wt% of water.
Wherein the organic acid comprises tartaric acid, malic acid, citric acid and succinic acid.
Preferably, in the plant fermentation desensitizing composition, the polyphenol is 0.08-2 parts by weight, preferably 0.08-1 part by weight, and more preferably 0.1-0.8 part by weight.
Preferably, in the plant fermentation desensitizing composition, the crude polysaccharide is 1 to 5 parts by weight, preferably 1.5 to 3.0 parts by weight, and more preferably 2.5 to 3.0 parts by weight.
Preferably, in the plant fermentation desensitizing composition, the organic acid is 0.5 to 3 parts by weight, preferably 0.5 to 1.0 part by weight.
Preferably, the plant fermentation allergy-relieving composition comprises 0.4-0.6 part by weight of polyphenol, 2.5-3.0 parts by weight of crude polysaccharide and 0.8-1.0 part by weight of organic acid.
Preferably, in the above plant fermentation allergy-relieving composition, the allergy-relieving composition is obtained by fermenting yeast in a plant fermentation substrate, and the fermentation substrate includes chamomile, centella asiatica, peony, notoginseng, purslane, cactus and scutellaria baicalensis.
Preferably, in the above plant fermentation allergy-relieving composition, the fermentation substrate comprises chamomile 0.1-30 parts by weight, centella asiatica 0.1-10 parts by weight, peony 0.1-20 parts by weight, notoginseng 0.1-5 parts by weight, purslane 0.1-30 parts by weight, cactus 0.1-30 parts by weight and scutellaria baicalensis 0.1-5 parts by weight.
Preferably, in the above plant fermentation allergy-relieving composition, the fermentation substrate comprises chamomile 0.1-30 parts by weight, centella asiatica 5-10 parts by weight, peony 0.1-20 parts by weight, notoginseng 3-5 parts by weight, purslane 0.1-30 parts by weight, cactus 4.5-30 parts by weight and scutellaria baicalensis 0.1-5 parts by weight.
Preferably, in the plant fermentation allergy-relieving composition, the fermentation substrate comprises 20-30 parts by weight of chamomile and 15-20 parts by weight of peony.
Preferably, in the above plant fermentation allergy-relieving composition, the fermentation substrate comprises 30 parts by weight of chamomile, 10 parts by weight of centella asiatica, 20 parts by weight of peony, 5 parts by weight of notoginseng, 0.1-30 parts by weight of purslane, 4.5-30 parts by weight of cactus and 0.1-5 parts by weight of scutellaria baicalensis.
Preferably, in the above plant fermentation allergy-relieving composition, the fermentation substrate comprises 30 parts by weight of chamomile, 10 parts by weight of centella asiatica, 20 parts by weight of peony, 5 parts by weight of notoginseng, 0.1-0.5 part by weight of purslane, 29.5-29.9 parts by weight of cactus and 5 parts by weight of scutellaria baicalensis.
Preferably, in the above plant fermentation allergy-relieving composition, the fermentation substrate comprises one or more of witch hazel, folium artemisiae argyi, grape seed, blueberry, ginkgo, hawthorn, licorice extract or glycyrrhizic acid, aloe, chamomile blue, astragalus membranaceus, honeysuckle, indigowoad root flower, peony, kiwi fruit, roxburgh rose, calendula, lotus seed, snow lotus, ginseng, lavender, seaweed, honeysuckle, coix seed, ganoderma, green tea and poria cocos.
The invention also provides a preparation method of the plant fermentation allergy-relieving composition, which comprises the following steps:
mixing the components in the fermentation substrate, adding water, heating to 100-120 ℃, sterilizing, cooling to 20-35 ℃, inoculating a fermentation strain for fermentation, and filtering and sterilizing to obtain the plant fermentation allergy-relieving composition.
Preferably, in the above preparation method, the fermentation bacteria is selected from lactic acid bacteria and/or yeast.
Preferably, in the above preparation method, the mass ratio of the fermentation substrate to water is 1 (5-100), preferably 1 (10-50).
Preferably, in the above preparation method, the temperature-raising treatment time is 10 to 60 min.
Preferably, in the preparation method, the fermentation time is 3-120 h; preferably, the fermentation time is 24-96 h.
The invention also provides application of the plant fermentation allergy-relieving composition in the fields of skin care products, cosmetics or medicines.
The invention has the advantages that: the composition provided by the invention can relieve skin allergy, resist bacteria and inflammation, promote skin cell renewal and achieve the effects of resisting allergy and relieving.
Detailed Description
In view of the fact that the safety and the efficacy of the existing skin allergy-relieving agent are still to be improved, the invention provides a plant fermentation allergy-relieving agent and a preparation method and application thereof.
In a preferred embodiment, the fermentation substrate of the soothing agent comprises chamomile 0.1-30%, centella asiatica 0.1-10%, peony 0.1-20%, notoginseng 0.1-5%, purslane 0.1-30%, cactus 0.1-30%, and scutellaria baicalensis 0.1-5%.
The preparation process comprises the following steps: crushing, mixing, sterilizing, fermenting, filtering and filling.
In another preferred embodiment, the process for preparing the soothing agent of the invention comprises the following steps: pulverizing the above Chinese medicinal materials, mixing at a certain proportion, adding 5-100 times (m/m) of purified water, treating at 120 deg.C for 10-60min at 100 deg.C, cooling to 20-35 deg.C, inoculating yeast or lactobacillus, fermenting for 3-120h, filtering, sterilizing, and bottling to obtain the final product.
The plant fermentation sensitizer of the present invention, its preparation method and application are further illustrated by the following specific examples.
In the following examples, the information on the raw materials used is as follows:
HaCaT cells (human immortalized keratinocytes) used in this assay were purchased from Shangen cell Bank, cell catalog number SNL-163.
Yeast, manufacturer: angel Yeast, Inc., model number: high activity dry yeast; the goods number is: 2018091221.
lactic acid bacteria, manufacturer: angel Yeast, Inc., Cathaki, Inc.: 20190909.
chamomile, centella asiatica, peony, pseudo-ginseng, purslane, cactus and scutellaria baicalensis, and the sources are as follows: xianchang Yue Biotechnology Co., Ltd.
Example 1
Crushing the Chinese herbal medicines in the example 1 in the table 1 to 40 meshes, mixing the Chinese herbal medicines according to the proportion in the example 1 in the table 1, adding 5 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 1 in the table 2, stirring the mixture at 100 ℃ for 60min, cooling the mixture to 20 ℃, adding 0.1 wt% of yeast, fermenting the mixture for 3h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 1h at 95 ℃, and filling the mixture to obtain the finished product of the soothing agent.
Detecting a finished product of the comfort agent: the polyphenol content is determined according to the method specified in appendix A of GB/T31740.2, the crude polysaccharide content is determined according to the method specified in SN/T4260, the organic acid content (total amount of tartaric acid, malic acid, citric acid and succinic acid) is determined according to the method specified in GB5009.157, and the water content is determined according to the method specified in NY/T2321.
Through detection, the components in the desensitizer product obtained in example 1 are 0.08% of polyphenol, 0.8% of crude polysaccharide, 0.2% of organic acid and 92% of water.
Example 2
Crushing the Chinese herbal medicines in the table 1 to 80 meshes, mixing the Chinese herbal medicines according to the proportion in the example 2 in the table 1, adding 100 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 2 in the table 2, stirring the mixture at 120 ℃ for 10min at the stirring speed of 100r/min, cooling the mixture to 35 ℃, inoculating 0.1 wt% of yeast, fermenting the mixture for 12h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 0.5h at 121 ℃, and filling the mixture to obtain the finished product of the allergy-relieving agent.
The detection shows that the components of the obtained soothing agent product comprise 0.05% of polyphenol, 0.6% of crude polysaccharide, 0.2% of organic acid and 98% of water.
Example 3
Crushing the Chinese herbal medicines in the table 1 to 20 meshes, mixing the Chinese herbal medicines according to the proportion in the example 3 in the table 1, adding 5 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 3 in the table 2, stirring the mixture at 100 ℃ for 60min at the stirring speed of 100r/min, cooling the mixture to 25 ℃, inoculating 1 wt% of yeast, fermenting the mixture for 72h, filtering the mixture after the fermentation is finished, sterilizing the mixture at 100 ℃ for 0.5h, and filling the mixture to obtain the finished product of the soothing agent.
Through detection, the components in the obtained soothing agent product comprise 0.3% of polyphenol, 2.4% of crude polysaccharide, 0.2% of organic acid and 92% of water.
Example 4
Crushing the Chinese herbal medicines in the table 1 to 80 meshes, mixing the Chinese herbal medicines according to the proportion of example 4 in the table 1, adding 100 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition of example 4 in the table 2, stirring the mixture at 120 ℃ for 20min at the stirring speed of 100r/min, cooling the mixture to 30 ℃, inoculating 1 wt% of yeast, fermenting the mixture for 120h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 2h at 90 ℃, and filling the mixture to obtain the finished product of the soothing agent.
The detection shows that the components of the obtained soothing agent product comprise 0.05% of polyphenol, 0.9% of crude polysaccharide, 0.2% of organic acid and 98% of water.
Example 5
Crushing the Chinese herbal medicines in the table 1 to 60 meshes, mixing according to the proportion in the example 5 in the table 1, adding 10 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 5 in the table 2, stirring at 120 ℃ for 20min at the stirring speed of 100r/min, cooling to 20 ℃, inoculating 2 wt% of lactic acid bacteria, fermenting for 24h, filtering after fermentation, sterilizing at 100 ℃ for 1h, and filling to obtain the finished product of the soothing agent.
Through detection, the components in the obtained soothing agent product comprise 0.5% of polyphenol, 2.8% of crude polysaccharide, 0.8% of organic acid and 87% of water.
Example 6
Crushing the Chinese herbal medicines in the table 1 to 20 meshes, mixing the Chinese herbal medicines according to the proportion in the example 6 in the table 1, adding 50 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 6 in the table 2, treating the mixture at 100 ℃ for 40min, cooling the mixture to 35 ℃, inoculating 2 wt% of lactic acid bacteria, fermenting the mixture for 48h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 1h at 100 ℃, and filling the mixture to obtain the finished product of the soothing agent.
The detection shows that the components of the obtained soothing agent product are 0.06% of polyphenol, 0.9% of crude polysaccharide, 0.6% of organic acid and 95% of water.
Example 7
Crushing the Chinese herbal medicines in the table 1 to 40 meshes, mixing the Chinese herbal medicines according to the proportion of example 7 in the table 1, adding 20 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition of example 7 in the table 2, stirring the mixture at 120 ℃ for 20min at the stirring speed of 100r/min, cooling the mixture to 25 ℃, inoculating 0.5 wt% of lactic acid bacteria, fermenting the mixture for 96h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 2h at 80 ℃, and filling the mixture to obtain the finished allergy-relieving agent.
Through detection, the components in the obtained soothing agent product comprise 0.09% of polyphenol, 1.9% of crude polysaccharide, 0.7% of organic acid and 90% of water.
Example 8
Crushing the Chinese herbal medicines in the table 1 to 20 meshes, mixing the Chinese herbal medicines according to the proportion in the example 8 in the table 1, adding 20 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition in the example 8 in the table 2, stirring the mixture at the temperature of 120 ℃ for 20min at the stirring speed of 100r/min, cooling the mixture to 30 ℃, inoculating 0.5 wt% of lactic acid bacteria, fermenting the mixture for 72h, filtering the mixture after the fermentation is finished, sterilizing the mixture at the temperature of 121 ℃ for 0.5h, and filling the mixture to obtain the finished allergy-relieving agent.
The detection shows that the components of the obtained soothing agent product comprise 0.08% of polyphenol, 2.1% of crude polysaccharide, 0.09% of organic acid and 96% of water.
Example 9
Crushing the Chinese herbal medicines in the table 1 to 80 meshes, mixing the Chinese herbal medicines according to the proportion of example 9 in the table 1, adding 10 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition of example 9 in the table 2, heating and sterilizing the mixture at 120 ℃ for 20min, cooling the mixture to 35 ℃, inoculating 2 wt% of lactic acid bacteria, fermenting the mixture for 120h, filtering the mixture after the fermentation is finished, sterilizing the mixture for 1h at 100 ℃, and filling the mixture to obtain the finished product of the allergy-relieving agent.
Through detection, the components in the allergy-relieving agent product comprise 2% of polyphenol, 5% of crude polysaccharide, 3% of organic acid and 90% of water.
Example 10
Crushing the Chinese herbal medicines in the table 1 to 80 meshes, mixing the Chinese herbal medicines according to the proportion of example 10 in the table 1, adding 20 times of water by mass into the Chinese herbal medicine mixture according to the fermentation condition of the example 10 in the table 2, heating and sterilizing the mixture at 100 ℃ for 30min, cooling the mixture to 28 ℃, inoculating 1 wt% of yeast, fermenting the mixture for 96h, filtering the mixture after the fermentation is finished, sterilizing the mixture at 120 ℃ for 15min, and filling the mixture to obtain the finished product of the allergy-relieving agent. The detection shows that the components in the allergy-relieving agent product comprise 1% of polyphenol, 3.5% of crude polysaccharide, 1.5% of organic acid and 93% of water.
Comparative example 1
The fermentation substrate is: 0.3 percent of chamomile, 85.5 percent of purslane and 14.2 percent of scutellaria baicalensis, and the soothing agent product is prepared according to the same method as the embodiment 1.
The detection shows that the components of the obtained soothing agent product comprise 0.05% of polyphenol, 0.8% of crude polysaccharide, 0% of organic acid and 95% of water.
Table 1 example fermentation substrate composition and proportions
TABLE 2 fermentation conditions of the examples
The products of the phlegmatizers obtained in examples 1 to 10 and comparative examples were used in cytology experiments as follows:
after HACaT cells were stimulated to model with SLS (sodium dodecyl sulfate), lyophilized powder (concentration of 0.2mg/mL) of the composition of examples 1-8 was allowed to act together with HaCaT cells for 24 hours, and then the growth rate of ROS (reactive oxygen species), SOD (superoxide dismutase), and MDA (malondialdehyde) in HaCaT cells was measured at a concentration of 0.2mg/mL as compared to that in the model group. The specific experimental method is as follows:
1. stimulation model making
Culture of HaCaT cells: the HaCaT cells were recovered and inoculated into 12-well plates at a plating density of 50% in a DMEM-high sugar medium (Gibco Co., Ltd.) at 37 ℃ with 5% CO2Culturing in an incubator for 24h under the condition.
Cell passage: changing the culture medium to fresh DMEM-high sugar culture solution; HaCaT cells are inoculated into a culture flask, SLS solution with the concentration of 50ug/mL is added, and the mixture is cultured for 24 hours in a 5% CO2 incubator at 37 ℃.
2. The compositions described in examples 1-10 and comparative examples were prepared as lyophilized powders by the following procedure:
and (3) putting the solution obtained in each embodiment into a freeze dryer, and drying to obtain the freeze-dried powder of the composition product in each embodiment.
3. Taking the examples 1-10 and the comparative example as model groups, adding 0.2mg/mL of freeze-dried powder of the composition obtained in the examples 1-10 into a cell culture solution to obtain experimental groups 1-10; after culturing in a 5% CO2 incubator at 37 ℃ for 24 hours, the growth rate of ROS (reactive oxygen species), SOD (superoxide dismutase) and MDA (malondialdehyde) of the HaCaT cells was examined compared with that of the model group. The results are shown in Table 3.
The ROS detection method comprises the following steps: ELISA kit method (BD Co.); the detection method of SOD comprises the following steps: ELISA kit method (BD Co.); the detection method of MDA comprises the following steps: ELISA kit method (BD Co.).
TABLE 3 cytological Experimental results
ROS and MDA are oxidation factors generated by skin cells due to external stimulation, and SOD is an oxidation factor. The results show that the ingredients of the examples are effective in relieving oxidative damage caused by irritation.
In conclusion, the plant fermentation allergy-relieving agent disclosed by the invention can relieve skin allergy, resist bacteria and diminish inflammation, promote skin cell renewal and achieve the effects of resisting allergy and relieving after the active ingredients in natural plants are subjected to appropriate structural modification.
Claims (13)
1. The plant fermentation allergy-relieving composition is characterized by comprising the following components:
0.05-2 parts of polyphenol, 0.5-5 parts of crude polysaccharide and 0.1-3 parts of organic acid.
2. The phytofermentant phlegmatism composition according to claim 1, wherein the polyphenol is present in an amount of 0.08-2 parts by weight, preferably 0.08-1 parts by weight, more preferably 0.1-0.8 parts by weight.
3. Plant fermentation phlegmatism-relieving composition according to claim 1 or 2, wherein the crude polysaccharide is present in an amount of 1 to 5 parts by weight, preferably 1.5 to 3.0 parts by weight, more preferably 2.5 to 3.0 parts by weight.
4. Plant fermentation soothing composition according to any of the claims 1-3, wherein the organic acid is present in an amount of 0.5-3 parts by weight, preferably 0.5-1.0 parts by weight.
5. The plant fermented soothing composition according to any one of claims 1 to 4, wherein the soothing composition is obtained by fermenting yeast in a plant fermentation substrate comprising chamomile, centella asiatica, peony, notoginseng, purslane, cactus and scutellaria baicalensis.
6. The plant fermentation allergy-relieving composition of claim 5, wherein the fermentation substrate comprises chamomile 0.1-30 parts by weight, centella asiatica 0.1-10 parts by weight, peony 0.1-20 parts by weight, notoginseng 0.1-5 parts by weight, purslane 0.1-30 parts by weight, cactus 0.1-30 parts by weight and scutellaria baicalensis 0.1-5 parts by weight.
7. The plant fermentation allergy-relieving composition of claim 6, wherein the fermentation substrate comprises chamomile 0.1-30 parts by weight, centella asiatica 5-10 parts by weight, peony 0.1-20 parts by weight, notoginseng 3-5 parts by weight, purslane 0.1-30 parts by weight, cactus 4.5-30 parts by weight and scutellaria baicalensis 0.1-5 parts by weight.
8. The plant fermentation allergy-relieving composition according to claim 6 or 7, wherein the fermentation substrate comprises 20 to 30 parts by weight of chamomile and 15 to 20 parts by weight of peony.
9. The plant fermented allergy relief composition according to any one of claims 5 to 8, wherein the fermentation substrate comprises one or more of witch hazel, mugwort leaf, grape seed, blueberry, ginkgo biloba, hawthorn, licorice extract or glycyrrhizic acid, aloe, chamomile blue, astragalus, honeysuckle, indigowoad root bloom, peony, kiwi, rosa roxburghii, calendula, lotus seed, snow lotus, ginseng, lavender, seaweed, honeysuckle, coix seed, ganoderma lucidum, green tea and poria cocos.
10. A process for the preparation of a plant fermentation soothing composition according to any one of claims 1 to 9, comprising the steps of:
mixing the components in the fermentation substrate, adding water, heating to 100-120 ℃, sterilizing, cooling to 20-35 ℃, inoculating a fermentation strain for fermentation, and filtering and sterilizing to obtain the plant fermentation allergy-relieving composition.
11. The method according to claim 10, wherein the fermentation strain is selected from lactic acid bacteria and/or yeast.
12. The method according to claim 10 or 11, wherein the mass ratio of the fermentation substrate to the water is 1 (5-100), preferably 1 (10-50).
13. Use of a phytofermentant phlegmatism composition according to any of claims 1-9 in the field of skin care, cosmetics or pharmaceuticals.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011539786.6A CN114652763B (en) | 2020-12-23 | 2020-12-23 | Plant fermentation allergy-relieving composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011539786.6A CN114652763B (en) | 2020-12-23 | 2020-12-23 | Plant fermentation allergy-relieving composition and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114652763A true CN114652763A (en) | 2022-06-24 |
CN114652763B CN114652763B (en) | 2023-11-07 |
Family
ID=82024877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011539786.6A Active CN114652763B (en) | 2020-12-23 | 2020-12-23 | Plant fermentation allergy-relieving composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114652763B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116035995A (en) * | 2023-02-17 | 2023-05-02 | 广州锦同生物科技有限公司 | Seven-piece cosmetic composition and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105769654A (en) * | 2016-03-02 | 2016-07-20 | 名臣健康用品股份有限公司 | Anti-sensitivity skin-care composition and application thereof to cosmetics |
CN110604299A (en) * | 2019-10-23 | 2019-12-24 | 华南协同创新研究院 | Rosa roxburghii mushroom oral liquid and preparation method thereof |
CN110833581A (en) * | 2019-12-11 | 2020-02-25 | 广州诺胜化妆品有限公司 | Anti-allergy composition, preparation method thereof, anti-allergy cosmetic and preparation method thereof |
-
2020
- 2020-12-23 CN CN202011539786.6A patent/CN114652763B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105769654A (en) * | 2016-03-02 | 2016-07-20 | 名臣健康用品股份有限公司 | Anti-sensitivity skin-care composition and application thereof to cosmetics |
CN110604299A (en) * | 2019-10-23 | 2019-12-24 | 华南协同创新研究院 | Rosa roxburghii mushroom oral liquid and preparation method thereof |
CN110833581A (en) * | 2019-12-11 | 2020-02-25 | 广州诺胜化妆品有限公司 | Anti-allergy composition, preparation method thereof, anti-allergy cosmetic and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116035995A (en) * | 2023-02-17 | 2023-05-02 | 广州锦同生物科技有限公司 | Seven-piece cosmetic composition and application thereof |
CN116035995B (en) * | 2023-02-17 | 2023-09-05 | 广州锦同生物科技有限公司 | Seven-piece cosmetic composition and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114652763B (en) | 2023-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108245479B (en) | Facial mask containing bifidobacterium lactis fermented active extract | |
KR101041403B1 (en) | Cosmetic Composition for Anti-oxidation and Whitening | |
CN108815072B (en) | Fresh plant composition fermented raw pulp with moisturizing and relieving effects and preparation method and application thereof | |
CN110934803B (en) | Plant fermentation composition with whitening and spot-fading functions | |
CN112190593B (en) | Polysaccharide composition for inhibiting TRPV1 pathway and preparation method and application thereof | |
CN115025026B (en) | Natural plant extract composition with relieving, repairing and anti-allergic effects | |
CN113520942B (en) | Anti-oxidation and anti-aging five-ginseng fermentation product and preparation method and application thereof | |
CN115531272B (en) | Antioxidant composition derived from alpine plants and preparation method and application thereof | |
CN108042436B (en) | Anti-aging and moisturizing blue copper peptide essence cream | |
KR20110016611A (en) | Cosmetic compositions for atopy therapy and the same | |
CN108670933B (en) | Skin care composition with moisturizing, whitening and anti-aging functions and application thereof | |
CN107157859A (en) | A kind of face mask of traditional Chinese medicine with nti-freckle, whitening and nourishing effect and preparation method thereof | |
CN114652763B (en) | Plant fermentation allergy-relieving composition and preparation method and application thereof | |
CN116350563B (en) | Plant co-fermentation composition and preparation method and application thereof | |
CN104546621A (en) | Anti-aging skincare composition and preparation method thereof | |
KR101710005B1 (en) | Cosmetic composition comprising cheonjeongpalgindan as active ingredient | |
CN113749971A (en) | Skin care formula with anti-aging, whitening, moisturizing and skin care functions and preparation method thereof | |
KR101985660B1 (en) | Cosmetic composition for treating acne containing mixed herbal extracts fermented with Nuruk | |
CN111904911B (en) | Panax notoginseng-containing plant antioxidant composition and application thereof | |
CN115006328B (en) | Whitening and freckle-removing composition, and preparation method and application thereof | |
CN115245475B (en) | Application of six-monarch fermentation product in preparing Chinese herbal medicine cosmetic composition with antioxidant, moisturizing and oil control effects | |
CN114917175B (en) | Anti-aging composition | |
CN114732777B (en) | Composition with moisturizing and soothing effects and preparation method thereof | |
TWI793940B (en) | Method for preparing ferment of saussurea involucrata and skin complexion improved composition | |
KR102446610B1 (en) | Cleansing composition having increased scopolin, scopoletin and ginsenosides and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |